ESC Premium Access

Rewriting the textbooks: SGLT2 inhibitors and cardiovascular disease in type 2 diabetes

Event: ESC CONGRESS 2019
Topic: Cardiovascular Disease in Special Populations
Session type: Satellite Symposium
Sponsored by the Mundipharma network of independent associated companies
Date: 1 September 2019
Time: 18:15 - 19:45

Congress Session

4 presentations in this session

Welcome and objectives.

Speaker: Professor F. Cosentino (Stockholm, SE)
Thumbnail

Cardiovascular risk management in the era of SGLT2is

Speaker: Professor M. Cowie (London, GB)
Thumbnail

Heart failure with and without chronic kidney disease in type 2 diabetes

Speaker: Professor O. Schnell (Munich, DE)
Thumbnail

Interactive panel discussion

Speaker: Professor F. Cosentino (Stockholm, SE)
Speaker: Professor M. Cowie (London, GB)
Speaker: Professor O. Schnell (Munich, DE)
Thumbnail

6 speakers from this session

Professor Francesco Cosentino

Unit of Cardiology, Karolinska Institute & Karolinska University Hospital, Stockholm (Sweden)
22 presentations
0 follower

Professor Martin Cowie

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
93 presentations
3 followers

Professor Oliver Schnell

Sciarc GmbH, Munich (Germany)
3 presentations
0 follower

Professor Francesco Cosentino

Unit of Cardiology, Karolinska Institute & Karolinska University Hospital, Stockholm (Sweden)
22 presentations
0 follower

Professor Martin Cowie

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
93 presentations
3 followers

Professor Oliver Schnell

Sciarc GmbH, Munich (Germany)
3 presentations
0 follower

This platform is supported by

logo Novo Nordisk